Johnson & Johnson traded at $179.52 this Friday July 1st, increasing $2.01 or 1.13 percent since the previous trading session. Looking back, over the last four weeks, J&J gained 1.34 percent. Over the last 12 months, its price rose by 6.24 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 177.39 by the end of this quarter and at 163.45 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
179.52
Daily Change
1.13%
Yearly
6.24%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.80 0.64 0.42% 33.54%
Abiomed 254.56 7.05 2.85% -19.70%
Abbott 110.22 1.57 1.45% -6.62%
Amgen 245.55 2.25 0.92% -1.27%
AstraZeneca 10,754.00 -46.00 -0.43% 22.50%
Astrazeneca 65.95 -0.12 -0.18% 8.49%
Baxter International 65.49 1.26 1.96% -19.90%
Bayer 57.35 0.63 1.11% 11.42%
Becton, Dickinson and Co. 251.80 5.27 2.14% 1.35%
Biogen 210.63 6.69 3.28% -39.60%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Boston Scientific 38.01 0.74 1.99% -13.46%
CONMED 96.89 1.13 1.18% -30.23%
Cooper Companies 318.51 5.39 1.72% -21.89%
Cardiovascular Systems 14.57 0.21 1.46% -65.85%
Dexcom 77.63 3.10 4.16% -82.01%
Edwards Lifesciences 97.39 2.30 2.42% -8.63%
Gilead Sciences 62.36 0.55 0.89% -10.01%
Globus Medical 57.72 1.58 2.81% -26.71%
GlaxoSmithKline 1,785.60 20.00 1.13% 24.19%
Hologic 70.14 0.84 1.21% 3.59%
Integra LifeSciences 55.00 0.97 1.80% -21.32%
Intuitive Surgical 206.10 5.39 2.69% -78.03%
J&J 179.52 2.01 1.13% 6.24%
Eli Lilly 324.71 0.48 0.15% 38.79%
Medtronic 91.38 1.63 1.82% -27.95%
Merit Medical Systems 54.96 0.69 1.27% -14.15%
Merck & Co 92.42 1.25 1.37% 17.58%
Novartis 80.33 -0.52 -0.64% -4.96%
NuVasive 50.26 1.10 2.24% -25.43%
Pfizer 52.31 -0.12 -0.23% 31.66%
Insulet 226.46 8.52 3.91% -19.51%
Regeneron Pharmaceuticals 595.40 4.27 0.72% 2.01%
Roche Holding 320.40 1.85 0.58% -8.34%
Sanofi 97.52 1.18 1.22% 10.94%
Stryker 203.86 4.93 2.48% -23.19%
Teva Pharmaceutical Industries Ltd 2,670.00 -83.00 -3.01% -18.10%
Tandem Diabetes Care 61.81 2.62 4.43% -37.32%
Vertex Pharmaceuticals 287.32 5.53 1.96% 43.27%
Zimmer Biomet Holdings Inc 107.27 2.21 2.10% -34.40%
Zoetis 174.21 2.32 1.35% -9.60%

Indexes Price Day Year
US500 3825 39.95 1.06% -12.11%
US30 31097 321.83 1.05% -10.61%

J&J
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.